Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | ---- | 16.57%-316.59M | ---- | 5.82%-379.46M | ---- | 45.03%-402.89M | ---211.69M | -10.89%-732.95M | ---660.94M |
| Profit adjustment | |||||||||
| Interest (income) - adjustment | ---- | 40.96%-6.38M | ---- | -13.61%-10.8M | ---- | -479.57%-9.51M | ---3.94M | -893.94%-1.64M | ---165K |
| Impairment and provisions: | ---- | --27.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | --27.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -703.58%-14.15M | ---- | -103.17%-1.76M | ---- | -89.11%55.51M | --55.51M | -11.26%509.92M | --574.61M |
| -Other fair value changes | ---- | -703.58%-14.15M | ---- | -103.17%-1.76M | ---- | -89.11%55.51M | --55.51M | -11.26%509.92M | --574.61M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---555K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---555K | ---- |
| Depreciation and amortization: | ---- | -8.42%20.68M | ---- | 28.19%22.58M | ---- | 33.71%17.62M | --8.64M | 136.89%13.18M | --5.56M |
| -Depreciation | ---- | -17.21%10.28M | ---- | 4.25%12.41M | ---- | 53.18%11.91M | --5.82M | 195.25%7.77M | --2.63M |
| Financial expense | ---- | 126.31%3.45M | ---- | 93.65%1.52M | ---- | -11.67%787K | --416K | 50.76%891K | --591K |
| Exchange Loss (gain) | ---- | -1,764.58%-1.79M | ---- | 99.63%-96K | ---- | -386.00%-26.11M | ---14.74M | 208.17%9.13M | --2.96M |
| Special items | ---- | -54.85%34.21M | ---- | -27.02%75.77M | ---- | 191.93%103.83M | --50.83M | 392.26%35.57M | --7.23M |
| Operating profit before the change of operating capital | ---- | 13.37%-253.17M | ---- | -12.07%-292.24M | ---- | -56.65%-260.76M | ---114.98M | -137.29%-166.46M | ---70.15M |
| Change of operating capital | |||||||||
| Accounts receivable (increase)decrease | ---- | -14.81%23K | ---- | 184.38%27K | ---- | -366.67%-32K | ---81K | 129.27%12K | ---41K |
| Accounts payable increase (decrease) | ---- | 333.23%27.57M | ---- | 30.44%6.36M | ---- | -36.24%4.88M | --1.31M | 31.43%7.65M | --5.82M |
| prepayments (increase)decrease | ---- | 175.81%51.44M | ---- | -763.63%-67.85M | ---- | 156.49%10.22M | --7.72M | -2,281.45%-18.1M | ---760K |
| Cash from business operations | ---- | 50.77%-174.14M | ---- | -43.96%-353.7M | ---- | -38.89%-245.69M | ---106.04M | -171.61%-176.9M | ---65.13M |
| Special items of business | -6.58%-131.12M | 432.70%46.11M | 7.06%-123.02M | -298.51%-13.86M | -1,002.35%-132.36M | 151.17%6.98M | --14.67M | -422.28%-13.64M | ---2.61M |
| Net cash from operations | -6.58%-131.12M | 65.17%-128.04M | 7.06%-123.02M | -53.98%-367.55M | -44.86%-132.36M | -25.28%-238.71M | ---91.37M | -181.27%-190.54M | ---67.74M |
| Cash flow from investment activities | |||||||||
| Interest received - investment | -7.65%3.71M | -32.64%7.29M | -32.83%4.01M | 26.05%10.82M | 51.74%5.97M | 444.07%8.58M | --3.94M | 1,094.70%1.58M | --132K |
| Decrease in deposits (increase) | ---- | 200.00%42.5M | 198.02%42.5M | -617.61%-42.5M | -628.08%-43.36M | 200.00%8.21M | --8.21M | ---8.21M | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | --324K | ---- | ---- | --575K | ---- |
| Purchase of fixed assets | 90.95%-562K | -286.62%-10.4M | -361.86%-6.21M | 88.41%-2.69M | 92.81%-1.35M | 42.94%-23.22M | ---18.71M | -159.09%-40.7M | ---15.71M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---84.55M | ---- |
| Recovery of cash from investments | --230.43M | -0.01%222.38M | ---- | 3,286.61%222.4M | --112M | -98.14%6.57M | ---- | 52.54%352.65M | --231.18M |
| Cash on investment | ---187.44M | 53.65%-223.81M | ---- | -574,747.62%-482.87M | ---112M | 99.97%-84K | ---- | -36.96%-330.06M | ---241M |
| Other items in the investment business | -2,922.58%-937K | ---- | ---31K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 12.26%45.2M | 112.87%37.95M | 204.85%40.27M | -601,824.49%-294.85M | -484.86%-38.4M | 100.05%49K | ---6.57M | -328.11%-108.72M | ---25.4M |
| Net cash before financing | -3.82%-85.92M | 86.40%-90.09M | 51.54%-82.75M | -177.55%-662.4M | -74.36%-170.76M | 20.25%-238.66M | ---97.94M | -221.31%-299.26M | ---93.14M |
| Cash flow from financing activities | |||||||||
| New borrowing | 12.79%96.99M | 119.83%175.78M | 186.82%85.99M | --79.96M | --29.98M | ---- | ---- | -99.67%10K | --3M |
| Refund | -25.69%-75.39M | -502.45%-120.37M | ---59.98M | ---19.98M | ---- | ---- | ---- | 99.67%-10K | ---3M |
| Issuing shares | ---- | -29.84%215.94M | ---- | 62.36%307.79M | ---- | -76.33%189.57M | --189.57M | 186.56%800.98M | --279.51M |
| Interest paid - financing | -71.46%-2.45M | -126.31%-3.45M | -126.35%-1.43M | -93.65%-1.52M | -51.44%-630K | 11.67%-787K | ---416K | -50.76%-891K | ---591K |
| Issuance expenses and redemption of securities expenses | ---- | 87.29%-3.69M | ---- | -705.25%-28.99M | 70.83%-736K | -57.96%-3.6M | ---2.52M | 61.95%-2.28M | ---5.99M |
| Other items of the financing business | ---- | --140K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -25.31%16.06M | -21.78%258.93M | -16.08%21.51M | 84.54%331.04M | -86.10%25.63M | -77.38%179.38M | --184.37M | 194.15%793.03M | --269.6M |
| Effect of rate | -312.45%-2.35M | -42.87%1.79M | -81.17%1.11M | -88.02%3.14M | -60.13%5.88M | 386.98%26.17M | --14.76M | -207.31%-9.12M | ---2.97M |
| Net Cash | -14.06%-69.85M | 150.95%168.84M | 57.80%-61.24M | -458.97%-331.36M | -267.90%-145.13M | -112.01%-59.28M | --86.44M | 179.81%493.77M | --176.46M |
| Begining period cash | 55.58%477.6M | -51.67%306.98M | -51.67%306.98M | -4.95%635.21M | -4.95%635.21M | 263.87%668.33M | --668.33M | 1,704.80%183.67M | --10.18M |
| Items Period | ---- | ---9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | 64.23%405.4M | 55.58%477.6M | -50.23%246.85M | -51.67%306.98M | -35.55%495.97M | -4.95%635.21M | --769.52M | 263.87%668.33M | --183.67M |
| Cash balance analysis | |||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.